1-1 of 1
Alan S. M. Yong
Close
Sort by
Journal Articles

An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL

Clinical Trials & Observations
Adam S. Kittai, John N. Allan, Dan James, Helen Bridge, Miguel Miranda, Alan S. M. Yong, Fady Fam, Jack Roos, Vikram Shetty, Alan Skarbnik, Matthew S. Davids
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2861–2869.
https://doi.org/10.1182/bloodadvances.2023012142
Published: 2024
Includes: Supplemental data